Skip to main content
. 2010 Jun 30;36(1):339–354. doi: 10.1038/npp.2010.81

Figure 1.

Figure 1

After the administration of a placebo, a clinical improvement may occur for a variety of reasons. Whereas the clinical trialist is interested in any improvement that may take place in a clinical trial, the neurobiologist is only interested in the psychosocial–psychobiological effects after the administration of a placebo. These include a number of mechanisms, such as anxiety, reward, learning, and genetics.